Fas Ligand-mediated cytotoxicity of CD4+ T cells during chronic retrovirus infection. 2017

Anna Malyshkina, and Elisabeth Littwitz-Salomon, and Kathrin Sutter, and Gennadiy Zelinskyy, and Sonja Windmann, and Simone Schimmer, and Annette Paschen, and Hendrik Streeck, and Kim J Hasenkrug, and Ulf Dittmer
Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Anna.Malyshkina@uk-essen.de.

CD4+ helper T cells and cytotoxic CD8+ T cells are key players for adaptive immune responses against acute infections with retroviruses. Similar to textbook knowledge the most important function of CD4+ T cells during an acute retrovirus infection seems to be their helper function for other immune cells. Whereas there was no direct anti-viral activity of CD4+ T cells during acute Friend Virus (FV) infection, they were absolutely required for the control of chronic infection. During chronic FV infection a population of activated FV-specific CD4+ T cells did not express cytotoxic molecules, but Fas Ligand that can induce Fas-induced apoptosis in target cells. Using an MHC II-restricted in vivo CTL assay we demonstrated that FV-specific CD4+ T cells indeed mediated cytotoxic effects against FV epitope peptide loaded targets. CD4 + CTL killing was also detected in FV-infected granzyme B knockout mice confirming that the exocytosis pathway was not involved. However, killing could be blocked by antibodies against FasL, which identified the Fas/FasL pathway as critical cytotoxic mechanism during chronic FV infection. Interestingly, targeting the co-stimulatory receptor CD137 with an agonistic antibody enhanced CD4+ T cell cytotoxicity. This immunotherapy may be an interesting new approach for the treatment of chronic viral infections.

UI MeSH Term Description Entries
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females
D005622 Friend murine leukemia virus A strain of Murine leukemia virus (LEUKEMIA VIRUS, MURINE) producing leukemia of the reticulum-cell type with massive infiltration of liver, spleen, and bone marrow. It infects DBA/2 and Swiss mice. Friend Virus,Rowson-Parr Virus,Rowson Parr Virus,Virus, Friend,Virus, Rowson-Parr
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012192 Retroviridae Infections Virus diseases caused by the RETROVIRIDAE. Retrovirus Infections,Infections, Retroviridae,Infections, Retrovirus,XMRV Infection,Xenotropic MuLV-related Virus Infection,Xenotropic Murine Leukemia Virus-related Virus Infection,Infection, Retroviridae,Infection, Retrovirus,Infection, XMRV,Infections, XMRV,Retroviridae Infection,Retrovirus Infection,XMRV Infections,Xenotropic MuLV related Virus Infection,Xenotropic Murine Leukemia Virus related Virus Infection
D014412 Tumor Virus Infections Infections produced by oncogenic viruses. The infections caused by DNA viruses are less numerous but more diverse than those caused by the RNA oncogenic viruses. Fibroma, Shope,Papilloma, Shope,Infections, Tumor Virus,Infection, Tumor Virus,Shope Fibroma,Shope Papilloma,Tumor Virus Infection
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte

Related Publications

Anna Malyshkina, and Elisabeth Littwitz-Salomon, and Kathrin Sutter, and Gennadiy Zelinskyy, and Sonja Windmann, and Simone Schimmer, and Annette Paschen, and Hendrik Streeck, and Kim J Hasenkrug, and Ulf Dittmer
February 1997, Journal of immunology (Baltimore, Md. : 1950),
Anna Malyshkina, and Elisabeth Littwitz-Salomon, and Kathrin Sutter, and Gennadiy Zelinskyy, and Sonja Windmann, and Simone Schimmer, and Annette Paschen, and Hendrik Streeck, and Kim J Hasenkrug, and Ulf Dittmer
October 1997, Biochemical and biophysical research communications,
Anna Malyshkina, and Elisabeth Littwitz-Salomon, and Kathrin Sutter, and Gennadiy Zelinskyy, and Sonja Windmann, and Simone Schimmer, and Annette Paschen, and Hendrik Streeck, and Kim J Hasenkrug, and Ulf Dittmer
December 1996, Proceedings of the National Academy of Sciences of the United States of America,
Anna Malyshkina, and Elisabeth Littwitz-Salomon, and Kathrin Sutter, and Gennadiy Zelinskyy, and Sonja Windmann, and Simone Schimmer, and Annette Paschen, and Hendrik Streeck, and Kim J Hasenkrug, and Ulf Dittmer
May 1995, Journal of immunology (Baltimore, Md. : 1950),
Anna Malyshkina, and Elisabeth Littwitz-Salomon, and Kathrin Sutter, and Gennadiy Zelinskyy, and Sonja Windmann, and Simone Schimmer, and Annette Paschen, and Hendrik Streeck, and Kim J Hasenkrug, and Ulf Dittmer
January 2001, Journal of neuroimmunology,
Anna Malyshkina, and Elisabeth Littwitz-Salomon, and Kathrin Sutter, and Gennadiy Zelinskyy, and Sonja Windmann, and Simone Schimmer, and Annette Paschen, and Hendrik Streeck, and Kim J Hasenkrug, and Ulf Dittmer
August 1995, Immunological reviews,
Anna Malyshkina, and Elisabeth Littwitz-Salomon, and Kathrin Sutter, and Gennadiy Zelinskyy, and Sonja Windmann, and Simone Schimmer, and Annette Paschen, and Hendrik Streeck, and Kim J Hasenkrug, and Ulf Dittmer
July 2001, Journal of immunology (Baltimore, Md. : 1950),
Anna Malyshkina, and Elisabeth Littwitz-Salomon, and Kathrin Sutter, and Gennadiy Zelinskyy, and Sonja Windmann, and Simone Schimmer, and Annette Paschen, and Hendrik Streeck, and Kim J Hasenkrug, and Ulf Dittmer
June 1997, Journal of immunology (Baltimore, Md. : 1950),
Anna Malyshkina, and Elisabeth Littwitz-Salomon, and Kathrin Sutter, and Gennadiy Zelinskyy, and Sonja Windmann, and Simone Schimmer, and Annette Paschen, and Hendrik Streeck, and Kim J Hasenkrug, and Ulf Dittmer
July 2001, Journal of immunology (Baltimore, Md. : 1950),
Anna Malyshkina, and Elisabeth Littwitz-Salomon, and Kathrin Sutter, and Gennadiy Zelinskyy, and Sonja Windmann, and Simone Schimmer, and Annette Paschen, and Hendrik Streeck, and Kim J Hasenkrug, and Ulf Dittmer
April 1996, The Journal of experimental medicine,
Copied contents to your clipboard!